Prof. Elpis Hatziagorou

Cystic Fibrosis Centre, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

Diplomas

  • 1994: Medical School Diploma, MD, Aristotle University of Thessaloniki
  • 2004: Pediatrician, Aristotle University of Thessaloniki, Hippokration Hospital
  • 2007: Doctoral Thesis: “Contribution of exhaled NO in the evaluation of children with chronic lung disease”. Aristotle University of Thessaloniki
  • 2011: Teaching Certificate of Medical Education (“Educating the Teacher in Medical School”) (Medical Section), Aristotle University of Thessaloniki
  • 2012: European Diploma in Paediatric Respiratory Medicine, Hermes Examination in Paediatric Respiratory Medicine, European Respiratory Society

POST GRADUATE TRAINING - EXPERIENCE

  • 1996-1997: Clinical and Research Fellow, NICU, Hippokration Hospital of Thessaloniki
  • 1997-2000: Resident in Paediatrics, Infection Diseases Hospital of Thessaloniki
  • 2001-2002: Clinical and Research Fellow. Paediatric Respiratory Unit / 3rd Dept. of Paediatrics, Aristotle University of Thessaloniki
  • 2002-2004: Resident in Paediatrics, 3rd Dept. of Paediatrics, Aristotle University of Thessaloniki
  • 2004-2006: Clinical and Research Fellow, Paediatric Respiratory Unit / 3rd Dept. of Paediatrics, Hippokration Hospital, Aristotle University of Thessaloniki
  • 2010: Clinical Fellow in Respiratory Paediatrics, Sheffield Childrens’ Hospital, University of Sheffield, UK

FACULTY POSITIONS

  • 2006-2012: Consultant in Paediatrics, 3rd Dept. of Paediatrics , Hippokration Hospital,Aristotle University of Thessaloniki
  • 2012-2013: Lecturer in Respiratory Paediatrics, 3rd Dept. of Paediatrics Hippokration Hospital, Aristotle University of Thessaloniki
  • 2013- 2019: Assistant Professor in Respiratory Paediatrics, 3rd Dept. of Paediatrics Hippokration Hospital, Aristotle University of Thessaloniki
  • 2019 to date: Associate Professor in Respiratory Paediatrics, 3rd Dept. of Paediatrics Hippokration Hospital, Aristotle University of Thessaloniki

Memberships

  • Medical Council of Thessaloniki, Greece
  • National Greek Paediatric Society
  • National Greek Paediatric Respiratory Society
  • National Greek Respiratory Society
  • Greek Paediatric Society of Northern Greece
  • European Respiratory Society
  • European Cystic Fibrosis Society

Fields of interest

  • Cystic fibrosis
  • Asthma
  • NIV – children with special care needs (technology dependent children)

RECENT PEER REVIEWED PUBLICATIONS

  1. Olesen HV, Drevinek P, Gulmans VA, Hatziagorou E, Jung A, Mei-Zahav M, Stojnic N, Thomas M, Zolin A; ECFSPR Steering Group. Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al. J Cyst Fibros. 2019 Oct 31. pii: S1569-1993(19)30916-6.
  2. Hatziagorou E, Orenti A, Drevinek P, Kashirskaya N, Mei-Zahav M, De Boeck K; ECFSPR. Electronic address: ECFS-Patient.Registry@uz.kuleuven.ac.be; ECFSPR. Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis-data from the European cystic fibrosis society patient registry. J Cyst Fibros. 2019 Sep 3. pii: S1569-1993(19)30838-0.
  3. Chatzakis C, Floros D, Papagianni M, Tsiroukidou K, Kosta K, Vamvakis A, Koletsos N, Hatziagorou E, Tsanakas I, Mastorakos G. The Beneficial Effect of the Mobile Application Euglyca in Children and Adolescents with Type 1 Diabetes Mellitus: A Randomized Controlled Trial. Diabetes Technol Ther. 2019 Nov;21(11):627-634.
  4. Kampouras A, Hatziagorou E, Avramidou V, Georgopoulou V, Kirvassilis F, Hebestreit H, Tsanakas J. Ventilation efficiency to exercise in patients with cystic fibrosis. Pediatr Pulmonol. 2019 Oct;54(10):1584-1590. 
  5. Kougias V, Hatziagorou E, Laliotis N, Kyrvasillis F, Georgopoulou V, Tsanakas J. Two cases of myositis ossificans in children, after prolonged immobilization. J Musculoskelet Neuronal Interact. 2019 Mar 1;19(1):118-122.
  6. Parisi M, Grenda E, Hatziagorou E, Tsikopoulos G, Foroulis CN, Georgopoulou V, Anastasiou A, Tsiviki E, Tsanakas J. Chest wall lipoblastoma in a 3 year-old boy. Respir Med Case Rep. 2019 Jan 19;26:200-202
  7. Fieuws S, Hatziagorou E, De Boeck K. Predictors of Reduced Survival for Adult-diagnosed Cystic Fibrosis: Older Age at Diagnosis, a Substitute for Older Age? Ann Am Thorac Soc. 2019 May;16(5):644.
  8. Can environment or allergy explain international variation in prevalence of wheeze in childhood? Weinmayr G, Jaensch A, Ruelius AK, Forastiere F, Strachan DP; ISAAC Phase Two Study Group. Eur J Epidemiol. 2019 May;34(5):509-520.
  9. Hatziagorou E, Kouroukli E, Georgopoulou V, Tsanakas J. A Case Report of Pulmonary Exacerbation after Initiation of Lumacaftor/Ivacaftor Therapy in a CF Female with Complicated Lung Disease. Case Rep Pulmonol. 2018 May 30;2018:8394370.
  10. Hatziagorou E, Kouroukli E, Galogavrou M, Papanikolaou D, Terzi DD, Anagnostopoulou P, Kirvassilis F, Panagiotakos DB, Tsanakas J. Efficacy and safety of the combination fluticasone propionate plus salmeterol in asthmatic preschoolers: An observational study. J Asthma. 2019 Jun;56(6):573-580.
  11. Radtke T, Hebestreit H, Gallati S, Schneiderman JE, Braun J, Stevens D, Hulzebos EH, Takken T, Boas SR, Urquhart DS, Lands LC, Tejero S, Sovtic A, Dwyer T, Petrovic M, Harris RA, Karila C, Savi D, Usemann J, Mei-Zahav M, Hatziagorou E, Ratjen F, Kriemler S; CFTR-Exercise study group. CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis: A Cross-sectional Study. Ann Am Thorac Soc. 2018 Feb;15(2):209-216. 
  12. Avramidou V, Hatziagorou E, Kampouras A, Hebestreit H, Kourouki E, Kirvassilis F, Tsanakas J. Lung clearance index (LCI) as a predictor of exercise limitation among CF patients. Pediatr Pulmonol. 2018 Jan;53(1):81-87.
  13. Hatziagorou E, Kouroukli E, Avramidou V, Papagianni M, Papanikolaou D, Terzi D, Karailidou M, Kirvassilis F, Panagiotakos D, Tsanakas J.  "A real-life" study on height in prepubertal asthmatic children receiving inhaled steroids. J Asthma. 2018 Apr;55(4):437-442.
  14. Chrysochoou EA, Hatziagorou E, Kirvassilis F, Tsanakas J. Telephone monitoring and home visits significantly improved the quality of life, treatment adherence and lung function in children with cystic fibrosis. Acta Paediatr. 2017 Nov;106(11):1882.
  15. Avramidou V, Hatziagorou E, Kampouras A, Hebestreit H, Kourouki E, Kirvassilis F, Tsanakas J. Lung clearance index (LCI) as a predictor of exercise limitation among CF patients. Pediatr Pulmonol. 2017 Sep 26. doi: 10.1002/ppul.23833.
  16. Exercise responses are related to structural lung damage in CF pulmonary disease. Hatziagorou E, Kampouras A, Avramidou V, Georgopoulou V, Kirvasilis F, Kontouli K, Hebestreit H, Tsanakas J. Pediatr Pulmonol. 2016 May 12. doi: 10.1002/ppul.23474.
  17. Pancreatic Cystosis in Two Adolescents with Cystic Fibrosis. Hatziagorou E, Kampouras A, Sidiropoulou M, Markou A, Anastasiou A, Tsanakas J. Case Rep Pediatr. 2016;2016:5321785. doi: 10.1155/2016/5321785. Epub 2016 Mar 24.
  18. Use of lung clearance index to assess the response to intravenous treatment in cystic fibrosis. Hatziagorou E, Avramidou V, Kirvassilis F, Tsanakas J. Hippokratia. 2015 Jan-Mar;19(1):47-52. Long-term outcome of parapneumonic effusions in children: Lung function and exercise tolerance. Kontouli K, Hatziagorou E, Kyrvasilis F, Roilides E, Emporiadou M, Tsanakas J. Pediatr Pulmonol. 2014 Apr 29. doi: 10.1002/ppul.23054. [Epub ahead of print]
  19. Antioxidant foods consumption and childhood asthma and other allergic diseases: The Greek cohorts of the ISAAC II survey. Papadopoulou A, Panagiotakos DB, Hatziagorou E, Antonogeorgos G, Matziou VN, Tsanakas JN, Gratziou C, Tsabouri S, Priftis KN. Allergol Immunopathol . 2014. pii: S0301-0546(14)00096-2. doi: 10.1016/j.aller.2014.03.002. [Epub ahead of print]
  20. Dampness and moulds in relation to respiratory and allergic symptoms in children: results from Phase Two of the International Study of Asthma and Allergies in Childhood (ISAAC Phase Two). Weinmayr G, Gehring U, Genuneit J, Büchele G, Kleiner A, Siebers R, Wickens K, Crane J, Brunekreef B, Strachan DP; ISAAC Phase Two Study Group. Clin Exp Allergy. 2013 Jul;43(7):762-74
  21. Factors associated with FEV1 decline in cystic fibrosis: analysis of the data of the ECFS Patient Registry. Kerem E, Viviani L, Zolin A, Macneill S, Hatziagorou E, Ellemunter H, Drevinek P, Gulmans V, Krivec U, Olesen H; on behalf of the ECFS Patient Registry Steering Group. Eur Respir J. 2013 Apr 18. [Epub ahead of print]
  22. Determinants of quality of life in children with asthma. Petsios KT, Priftis KN, Hatziagorou E, Tsanakas JN, Antonogeorgos G, Matziou VN. Pediatr Pulmonol. 2013 Feb 8. doi: 10.1002/ppul.22768.
  23. Association of pertussis and measles infections and immunizations with asthma and allergic sensitization in ISAAC Phase Two. Nagel G, Weinmayr G, Flohr C, Kleiner A, Strachan DP; ISAAC Phase Two Study Group. Pediatr Allergy Immunol. 2012 Dec;23(8):737-46.
  24. Drug-resistant tuberculosis in two children in Greece: report of the first extensively drug-resistant case. Katragkou A, Antachopoulos C, Hatziagorou E, Sdougka M, Roilides E, Tsanakas J. Eur J Pediatr. 2013 Apr;172(4):563-7.
  25. Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis. Boëlle PY, Viviani L, Busson PF, Olesen HV, Ravilly S, Stern M, Assael BM, Barreto C, Drevinek P, Thomas M, Krivec U, Mei-Zahav M, Vibert JF, Clement A, Mehta A, Corvol H; French CF Modifier Gene Study Investigators; European CF Registry Working Group. Orphanet J Rare Dis. 2012 Sep 7;7:64.
  26. Tuberculosis, bacillus Calmette-Guérin vaccination, and allergic disease: findings from the International Study of Asthma and Allergies in Childhood Phase Two. Flohr C, Nagel G, Weinmayr G, Kleiner A, Williams HC, Aït-Khaled N, Strachan DP; ISAAC Phase Two Study Group. Pediatr Allergy Immunol. 2012 Jun;23(4):324-31.
  27. Level of parent-asthmatic child agreement on health-related quality of life. Petsios K, Priftis KN, Tsoumakas C, Hatziagorou E, Tsanakas JN, Galanis P, Antonogeorgos G, Matziou V. J Asthma. 2011 Apr;48(3):286-97.
  28. Lack of evidence for a protective effect of prolonged breastfeeding on childhood eczema: lessons from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Flohr C, Nagel G, Weinmayr G, Kleiner A, Strachan DP, Williams HC; ISAAC Phase Two Study Group. Br J Dermatol. 2011;165(6):1280-9.
  29. Comparison in asthma and allergy prevalence in the two major cities in Greece: the ISAAC phase II survey. Papadopoulou A, Hatziagorou E, Matziou VN, Grigoropoulou DD, Panagiotakos DB, Tsanakas JN, Gratziou C, Priftis KN. Allergol Immunopathol 2011:39(6):347-55.
  30. Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis. McCormick J, Mehta G, Olesen HV, Viviani L, Macek M Jr, Mehta A; European Registry Working Group. Lancet 2010; 375: 1007–13.
  31. Effect of diet on asthma and allergic sensitisation in the International Study on Allergies and Asthma in Childhood (ISAAC) Phase Two. Nagel G, Weinmayr G, Kleiner A, Garcia-Marcos L, Strachan DP; ISAAC Phase Two Study Group. Thorax. 2010; 65(6):516-22.
  32. International variations in associations of allergic markers and diseases in children: ISAAC Phase Two. Weinmayr G, Genuneit J, Nagel G, Björkstén B, van Hage M, Priftanji A, Cooper P, Rijkjärv MA, von Mutius E, Tsanakas J, Forastiere F, Doekes G, Garrido JB, Suarez-Varela MM, Bråbäck L, Strachan DP; ISAAC Phase Two Study Group. Allergy 2010; 65(6):766-75.
  33. International variations in bronchial responsiveness in children: findings from ISAAC phase two. Büchele G, Genuneit J, Weinmayr G, Björkstén B, Gehring U, von Mutius E, Priftanji A, Stein RT, Addo-Yobo EO, Priftis KN, Shah JR, Forastiere F, Svabe V, Crane J, Nystad W, García-Marcos L, Saraçlar Y, El-Sharif N, Strachan DP; ISAAC Phase Two Study Group. Pediatr Pulmonol. 2010 ;45(8):796-806.
  34. Asthma and allergic symptoms in relation to house dust endotoxin: Phase Two of the International Study on Asthma and Allergies in Childhood (ISAAC II) . U. Gehring, M. Strikwold, D. Schram-Bijkerk, G. Weinmayrw, J. Genuneitw, G. Nagelw, K. Wickensz, R. Siebersz, J. Cranez, G. Doekes, R. Di Domenicantonio, L. Nilssonz, A. Priftanjik, A. Sandin, N. El-Sharifww, D. Strachanzz, M. van Hage, E. von Mutiuszz, B. Brunekreef_kk and the ISAAC Phase Two Study Group. Clinical and Experimental Allergy 2008: 38, 1911–1920
  35. Aspergillus and the paediatric lung. Ε Hatziagorou, Τ Walsh , J Tsanakas, E Roilides . Paediatric Respiratory Reviews 10 (2009) 178–185.
04.02.2020